Related Experiment Video
Updated: Jul 24, 2026

10:05
Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)
Published on: January 20, 2016
Distamycin A modulates the sequence specificity of DNA alkylation by duocarmycin A
H Sugiyama1, C Lian, M Isomura
1Department of Synthetic Chemistry and Biological Chemistry, Faculty of Engineering, Kyoto University, Japan.
Summary
Duocarmycin A (Duo) typically targets DNA
Area of Science:
- DNA alkylation
- Drug-DNA interactions
- Structural biology
Background:
- Duocarmycin A (Duo) is a DNA alkylating agent that preferentially targets adenine (A) in A+T-rich sequences.
- Duo binds to the DNA minor groove as a monomer for efficient alkylation.
Purpose of the Study:
- To investigate how distamycin A (Dist) affects Duo's DNA alkylation site.
- To elucidate the structural basis for modulated DNA alkylation by Duo and Dist.
Main Methods:
- High-performance liquid chromatography (HPLC) for product analysis.
- Nuclear Overhauser effect (NOE)-restrained refinement using 750 MHz 2D NOE spectroscopy.
- Determination of the 3D structure of the ternary Duo/Dist/DNA complex.
Main Results:
- Distamycin A (Dist) redirects Duocarmycin A (Duo) alkylation from adenine (A) to guanine (G) in G+C-rich sequences.
- Cooperative binding of a Duo-Dist heterodimer to the DNA minor groove facilitates efficient G-N3 alkylation.
- The refined NMR structure of the ternary complex explains the sequence-specific alkylation modulation.
Conclusions:
- Cooperative binding between structurally distinct natural products (Duo and Dist) can predictably alter DNA alkylation selectivity.
- This study presents the first demonstration of Duo DNA alkylation via cooperative binding with another natural product.
- The findings suggest a novel strategy for modifying DNA alkylation patterns.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...

